SCHEMBL463384

SCHEMBL463384

C=CCNC(CCC)(C(=O)[O-])[N+](C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.33
FAAH O00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176115 0.77 ZDHHC20 (0.34) BBOX1
SCHEMBL19128769 0.75 PKM (0.30)
SCHEMBL3112719 0.74 EPHX1 (0.39)
SCHEMBL20599306 0.74 EPHX1 (0.39)
SCHEMBL1309532 0.73 MEN1 (0.33)
SCHEMBL1310807 0.71 ALDH1A1 (0.34)
SCHEMBL1312539 0.70 ALDH1A1 (0.41) BBOX1
SCHEMBL6334959 0.69
SCHEMBL1310785 0.68 ALDH1A1 (0.46) BBOX1FAAH
SCHEMBL1309574 0.67 ALDH1A1 (0.49) FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2115267-B1 HIGH PERFORMANCE FOAMS FOR UNLOADING GAS WELLS BAKER HUGHES A GE CO LLC (US) 2019-04-03 EP claimed
EP-2453869-B1 COMPOSITION AND METHOD INNOSPEC LTD (GB) 2016-11-02 EP claimed
EP-1730436-B1 POLYMERIC NANOEMULSION AS DRAG REDUCER FOR MULTIPHASE FLOW BAKER HUGHES INC (US) 2013-02-27 EP claimed
US-20080009429-A1 Cosmetic or dermatological cleansing compositions comprising secondary alkanesulfonates CLARIANT INTERNATIONAL LTD. 2008-01-10 US claimed
EP-1771148-B1 MILD, MOISTURIZING SULFOSUCCINATE CLEANSING COMPOSITIONS UNILEVER PLC (GB) 2007-12-05 EP claimed
EP-0719137-B1 VISCOUS SURFACTANT EMULSION COMPOSITIONS BIOSYN INC (US) 2002-02-20 EP claimed
EP-0958042-A1 FLUID CONCENTRATED HYDROALCOHOLIC COMPOSITIONS OF COPRA OR OIL PALM ALKYL-AMIDOPROPYLBETAINS CECA S.A. (FR) 1999-11-24 EP claimed
WO-1999024157-A1 FLUID CONCENTRATED HYDROALCOHOLIC COMPOSITIONS OF COPRA OR OIL PALM ALKYL-AMIDOPROPYLBETAINS CECA S.A. (FR) 1999-05-20 WO claimed
EP-0760402-A1 Carbon dioxide steel corrosion inhibition with synergetic, environmental friendly composition of N-acyl sarcosines and N-alkyl-amidopropylbetaines CECA S.A. (FR) 1997-03-05 EP claimed
EP-0442701-B1 Topical composition UNILEVER PLC (GB) 1996-04-24 EP claimed
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof BASF SE (DE) 2021-06-29 US disclosed
US-20190350239-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF BASF SE (DE) 2019-11-21 US disclosed
US-20170265510-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF BASF SE (DE) 2017-09-21 US disclosed
EP-2955070-A2 METHOD FOR CLEANING AND POLISHING A VEHICLE, VEHICLE TREATMENT SYSTEM AND CLEANING AND POLISHING AGENT WashTec Holding GmbH (DE) 2015-12-16 EP disclosed
US-20150307712-A1 ASPHALT COMPOSITION SHELL OIL COMPANY 2015-10-29 US disclosed
EP-0760402-A1 Carbon dioxide steel corrosion inhibition with synergetic, environmental friendly composition of N-acyl sarcosines and N-alkyl-amidopropylbetaines CECA S.A. (FR) 1997-03-05 EP disclosed
EP-0760402-A1 Carbon dioxide steel corrosion inhibition with synergetic, environmental friendly composition of N-acyl sarcosines and N-alkyl-amidopropylbetaines CECA S.A. (FR) 1997-03-05 EP disclosed
EP-0646369-A1 Cosmetic compositions comprising 1-hydroxy-2-pyridones as antidandruff and deodorant agents HOECHST AKTIENGESELLSCHAFT (DE) 1995-04-05 EP disclosed
EP-0099987-B1 HAIR TREATING COMPOSITION Henkel Kommanditgesellschaft auf Aktien (DE) 1986-08-20 EP disclosed
EP-0099987-A2 Hair treating composition Henkel Kommanditgesellschaft auf Aktien (DE) 1984-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170265510-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF TRPM8, TRPM7, TRPM2 BBOX1 3593/4885FAAH 980/4885
US-20080009429-A1 Cosmetic or dermatological cleansing compositions comprising secondary alkanesulfonates SMURF1, SMURF2, CUTA BBOX1 651/4885FAAH 332/4885
US-11044931-B2 Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof TRPM8, TRPM7, TRPM2 BBOX1 3593/4885FAAH 980/4885
US-20190350239-A1 LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF TRPM8, TRPM7, TRPM2 BBOX1 3593/4885FAAH 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.